% | $
Quotes you view appear here for quick access.

Genta Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • omniportent omniportent Jan 30, 2000 5:49 PM Flag

    re: cancer vaccines

    Thank you to all that answered my last post about
    the potential competition for GNTA. It will indeed be
    interesting to watch the progress of these various companies
    and their differing approaches to curing cancer. This
    is a very important topic.

    While I still am
    not sure where most of my money should go in the
    cancer vaccine/treatment race. I think there is a very
    interesting side issue: immune system response.

    think that everyone would agree that a drug used in
    conjunction with a cancer vaccine or treatment that could
    seriously boost immune response would be an excellent
    addition to the medical coctail. I believe such a drug
    exists and is already being marketed in I believe 13
    countries. It is in phase 2 in the U.S. It is called Zadaxin
    and is made by Sciclone Pharmaceuticals (SCLN). Not
    only does it significantly boost immune response, it
    has NO negative side effects. I believe g3139 would
    be even more effective when used in combination with
    this drug. By the way, Zadaxin is also being used in
    anti-AIDS cocktails too. Lastly, and far from least
    important, Zadaxin looks like it will be the best selling,
    most effective drug for Hep B and Hep C.

    those of you that don't want to put all your eggs in
    one anti-cancer basket, you might want to take a look
    at SCLN's Zadaxin because of its ability to be used
    in concert with many different therapies. This
    company also has a nice drug for CF in phase 2. All this
    and a market cap of 200 million

    I think I'll probably pick up some GNTA over the
    next week or two. I'll also accumulate my position in
    a few of the other lead cancer treatment companies.
    These shares in combination with my SCLN holdings
    should perform very nicely in the coming 1-2

    All the best!